250 related articles for article (PubMed ID: 14592689)
1. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
Redwine KE; Trujillo KA
Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
3. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
4. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
5. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
Craft RM; Lee DA
Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
[TBL] [Abstract][Full Text] [Related]
6. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
Baker AK; Hoffmann VL; Meert TF
Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
8. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
McNally GP; Westbrook RF
Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436
[TBL] [Abstract][Full Text] [Related]
10. Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats.
Holtman JR; Jing X; Wala EP
Pharmacol Biochem Behav; 2003 Sep; 76(2):285-93. PubMed ID: 14592680
[TBL] [Abstract][Full Text] [Related]
11. Evidence for opiate-activated NMDA processes masking opiate analgesia in rats.
Célèrier E; Laulin J; Larcher A; Le Moal M; Simonnet G
Brain Res; 1999 Nov; 847(1):18-25. PubMed ID: 10564731
[TBL] [Abstract][Full Text] [Related]
12. Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine.
Nishiyama T; Yaksh TL; Weber E
Anesthesiology; 1998 Sep; 89(3):715-22. PubMed ID: 9743410
[TBL] [Abstract][Full Text] [Related]
13. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats.
Allen RM; Dykstra LA
Psychopharmacology (Berl); 1999 Feb; 142(2):209-14. PubMed ID: 10102774
[TBL] [Abstract][Full Text] [Related]
14. Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time.
Nemmani KVS; Grisel JE; Stowe JR; Smith-Carliss R; Mogil JS
Pain; 2004 Jun; 109(3):274-283. PubMed ID: 15157688
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats.
Bespalov A; Kudryashova M; Zvartau E
Eur J Pharmacol; 1998 Jun; 351(3):299-305. PubMed ID: 9721021
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
17. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
Bhargava HN; Thorat SN
Brain Res; 1997 Feb; 747(2):246-51. PubMed ID: 9045999
[TBL] [Abstract][Full Text] [Related]
19. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice.
Popik P; Kozela E; Danysz W
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):425-32. PubMed ID: 10763858
[TBL] [Abstract][Full Text] [Related]
20. Interaction of memantine and ketamine in morphine- and pentazocine-induced antinociception in mice.
Malec D; Mandryk M; Fidecka S
Pharmacol Rep; 2008; 60(2):149-55. PubMed ID: 18443375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
